Revolution Medicines, Inc. is 27.7x more valuable than DBV Technologies S.A. by market capitalization ($30.74 B vs $1.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DBVT | RVMD |
|---|---|---|
| Market cap | $1.11 B | $30.74 B |
| US-listed rank | #2563 | #453 |
| Revenue (latest FY) | $5.64M | $0.00 |
| Net income (latest FY) | -$146.95M | -$1.13B |
| Net margin | -2607.3% | - |
| SEC filings | 563 | 782 |
Revolution Medicines, Inc. is 27.7x more valuable than DBV Technologies S.A. by market capitalization ($30.74 B vs $1.11 B).
In their latest fiscal years, DBV Technologies S.A. reported $5.64M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: DBV Technologies S.A. and Revolution Medicines, Inc., or browse the full rankings.